C01EB18
SpainRanolazine
-
Ranexa 375 mg prolonged-release tablets
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Menarini International Operations Luxembourg S.A.
-
Ranexa 500 mg prolonged-release tablets
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Menarini International Operations Luxembourg S.A.
-
Ranexa 750 mg prolonged-release tablets
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Menarini International Operations Luxembourg S.A.
-
Ranolazine Alter 375 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Alter S.A.
-
Ranolazine Alter 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Alter S.A.
-
Ranolazine Alter 750 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Alter S.A.
-
Ranolazine CINFA 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Cinfa S.A.
-
Ranolazine CINFA 750 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Cinfa S.A.
-
Ranolazine Cinfa 375 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Cinfa S.A.
-
Ranolazine Krka 375 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Krka D.D. Novo Mesto
-
Ranolazine Krka 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Krka D.D. Novo Mesto
-
Ranolazine Krka 750 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Krka D.D. Novo Mesto
-
Ranolazine Normon 375 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Normon S.A.
-
Ranolazine Normon 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Normon S.A.
-
Ranolazine Normon 750 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorios Normon S.A.
-
Ranolazine Pensa 375 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Towa Pharmaceutical S.A.
-
Ranolazine Pensa 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Towa Pharmaceutical S.A.
-
Ranolazine Pensa 750 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Towa Pharmaceutical S.A.
-
Ranolazine Stada 375 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorio Stada S.L.
-
Ranolazine Stada 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorio Stada S.L.
-
Ranolazine Stada 750 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Laboratorio Stada S.L.
-
Ranolazine Teva 375 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Teva Pharma S.L.U.
-
Ranolazine Teva 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Teva Pharma S.L.U.
-
Ranolazine Teva 750 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Teva Pharma S.L.U.
-
Ranozek 375 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 375 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Adamed Laboratorios S.L.U.
-
Ranozek 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 500 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Adamed Laboratorios S.L.U.
-
Ranozek 750 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage RANOLAZINE 750 mg ATC code: C01E, C01EB, C01EB18
Manufacturer: Adamed Laboratorios S.L.U.